Maravai LifeSciences Holdings, Inc. Business Combination, Contingent Consideration, Liability
Maravai LifeSciences Holdings, Inc. (MRVI) had Business Combination, Contingent Consideration, Liability of $4.94 million as of 2025-06-30, per its 10-Q filed 2025-08-11.
Financial Statements › Balance Sheet › Liabilities
us-gaap:BusinessCombinationContingentConsiderationLiability · last filed 2025-08-11
- 2025-06-30: Business Combination, Contingent Consideration, Liability $4.94M.
- 2025-03-31: Business Combination, Contingent Consideration, Liability $4.80M.
- 2024-12-31: Business Combination, Contingent Consideration, Liability $0.00.
- 2024-09-30: Business Combination, Contingent Consideration, Liability $630.00K.
| Period end | Business Combination, Contingent Consideration, Liability |
|---|---|
| 2025-06-30 | $4.94M 10-Q · filed 2025-08-11 |
| 2025-03-31 | $4.80M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $0.00 10-Q · filed 2025-08-11 |
| 2024-09-30 | $630.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $808.00K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $2.00M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $2.00M 10-K · filed 2025-03-18 |
| 2023-09-30 | $5.36M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $2.97M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $5.29M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $0.00 10-K · filed 2024-02-29 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-04 |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-05 |
| 2022-03-31 | $7.80M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $0.00 10-Q · filed 2023-11-08 |